Journal of Enzyme Inhibition and Medicinal Chemistry · 2017 · 25 citations · 25 references
MedicineMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryMolecular PharmacologyInherited Retinal DystrophiesRetinal DegenerationRetinal DiseaseRetinal DisordersRetinal PharmacotherapyGlycogen Synthase Kinase 3 SignalingInherited Retinal Dystrophy TherapyMedicinal Chemistry ApplicationsPharmacological PotencyRetinal Disease MechanismsRetinal NeuroprotectionRetinal PharmacologyRetinitis Pigmentosa Therapy
Retinitis pigmentosa (RP) is an inherited retinal dystrophy that courses with progressive degeneration of retinal tissue and loss of vision. Currently, RP is an unpreventable, incurable condition. We propose glycogen synthase kinase 3 (GSK-3) inhibitors as potential leads for retinal cell neuroprotection, since the retina is also a part of the central nervous system and GSK-3 inhibitors are potent neuroprotectant agents. Using a chemical genetic approach, diverse small molecules with different potency and binding mode to GSK-3 have been used to validate and confirm GSK-3 as a pharmacological target for RP. Moreover, this medicinal chemistry approach has provided new leads for the future disease-modifying treatment of RP.
25
Functional and structural modifications during retinal degeneration in the rd10 mouse
R. Barhoum, Silvia Corrochano, Francisco Germaín et al. · Neuroscience · 2008 · 196 citations · Full text